Abstract
Streptococcus pneumoniae (the pneumococcus) is a globally distributed, human obligate opportunistic bacterial pathogen which, although often carried commensally, is also a significant cause of invasive disease. Apart from multi-drug resistant and virulent clones, the rate and direction of pneumococcal dissemination between different countries remains largely unknown. The ability for the pneumococcus to take a foothold in a country depends on existing population configuration, the extent of vaccine implementation, as well as human mobility since it is a human obligate bacterium. To shed light on its international movement, we used extensive genome data from the Global Pneumococcal Sequencing (GPS) project and estimated migration parameters between multiple countries in Africa. Data on allele frequencies of polymorphisms at housekeeping-like loci for multiple different lineages circulating in the populations of South Africa, Malawi, Kenya, and The Gambia were used to calculate the fixation index (Fst) between countries. We then further used these summaries to fit migration coalescent models with the likelihood-free inference algorithms available in the ELFI software package. Synthetic data were additionally used to validate the inference approach. Our results demonstrate country-pair specific migration patterns and heterogeneity in the extent of migration between different lineages. Our approach demonstrates that coalescent models can be effectively used for inferring migration rates for bacterial species and lineages provided sufficiently granular population genomics surveillance data. Further it can demonstrate the connectivity of respiratory disease agents between countries to inform intervention policy in the longer term.
Competing Interest Statement
N.J.C. has consulted for Antigen Discovery Inc and Pfizer, and been invited to attend meetings funded by M.S.D. N.J.C. has received an investigator-initiated award from GlaxoSmithKline. No other authors have conflicts of interest to report.
Funding Statement
This GPS project was funded by the Bill and Melinda Gates Foundation (grant code OPP1034556). S.B. and S.D.B. were supported by the Wellcome Sanger Institute (core Wellcome grants WT098051, 206194, and 108413/A/15/D). N.J.C. was supported by the UK Medical Research Council and Department for International Development [MR/R015600/1, MR/T016434/1]; a Sir Henry Dale Fellowship, jointly funded by Wellcome and the Royal Society [104169/Z/14/A].
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The code and data associated with this paper are available at https://github.com/sophbel/LFI_between_country_migration/tree/main.
